Ammar Lulla brings a wealth of experience to the firm, having worked on major cross-border litigation, arbitration, and regulatory investigations across Asia, Europe, and the United States. His practice spans commercial litigation, white-collar defense, internal corporate investigations, and healthcare compliance — areas of increasing concern for multinational companies operating in Southeast Asia.
“This is a transformative moment for Tang Thomas,” said managing partner Fazilah Nazrin. “Ammar’s appointment adds considerable depth to our dispute resolution and healthcare teams. His experience aligns perfectly with the increasingly sophisticated needs of our clients.”
Lulla’s expertise in regulatory compliance and defense will be crucial in guiding pharmaceutical companies, biotech firms, and healthcare providers through Singapore’s tightly regulated legal environment. With the healthcare industry facing growing scrutiny and the need for innovation around issues like data privacy, patient safety, and cross-border telehealth, Tang Thomas is positioning itself as a go-to firm for both advisory and litigation support in this space.
On the disputes front, Lulla will play a lead role in representing clients in arbitration and litigation involving commercial contracts, corporate governance, fraud allegations, and regulatory violations. He has also worked on investor-state disputes and acted for both sovereign entities and Fortune 500 companies.
“I’m excited to be joining a team that is committed to innovation and excellence,” Lulla said. “Singapore is becoming a global legal hub, especially for cross-border disputes and healthcare innovation. I look forward to helping shape the firm’s continued growth in these sectors.”
The move comes amid increased demand for legal services in Asia-Pacific, particularly in specialized sectors like technology, healthcare, and life sciences, where legal frameworks are constantly evolving. Tang Thomas’ latest strategic hire is a clear signal of its ambition to meet these demands head-on.
